Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Blai, Dalmau"'
Autor:
Marta Gallach, Mercedes Vergara, Joao Pedro da Costa, Mireia Miquel, Meritxell Casas, Jordi Sanchez-Delgado, Blai Dalmau, Núria Rudi, Isabel Parra, Teresa Monllor, Meritxell Sanchez-Lloansí, Angelina Dosal, Oliver Valero, Xavier Calvet
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0241559 (2020)
[This corrects the article DOI: 10.1371/journal.pone.0208112.].
Externí odkaz:
https://doaj.org/article/5129c8b9691749f092aaacf1085dfd61
Autor:
Lara Albert, Joaquím Profitós, Jordi Sánchez-Delgado, Ismael Capel, José Miguel González-Clemente, David Subías, Albert Cano, Eugenio Berlanga, Anna Espinal, Marta Hurtado, Rocío Pareja, Mercedes Rigla, Blai Dalmau, Mercedes Vergara, Mireia Miquel, Meritxell Casas, Olga Giménez-Palop
Publikováno v:
International Journal of Endocrinology, Vol 2019 (2019)
Purpose. The prevalence of adrenal insufficiency (AI) in patients with decompensated liver cirrhosis is unknown. Because these patients have lower levels of cortisol-binding carrier proteins, their total serum cortisol (TSC) correlates poorly with fr
Externí odkaz:
https://doaj.org/article/e5b57baca2274f8c8bd0782e1d79261b
Autor:
Marta Gallach, Mercedes Vergara, Mireia Miquel, Meritxell Casas, Jordi Sánchez-Delgado, Blai Dalmau, Montserrat Gil, Núria Rudi, Isabel Parra, Maria López, Angelina Dosal, Laura Moreno, Oliver Valero, Xavier Calvet
Publikováno v:
Annals of Hepatology, Vol 15, Iss 4, Pp 524-531 (2016)
Background. Despite the introduction of direct antiviral agents, pegylated interferon remains the mainstay of treatment for chronic hepatitis C. However, pegylated interferon is associated with a high rate of severe adverse events and decreased quali
Externí odkaz:
https://doaj.org/article/299c63d1b30e46519f8415bd16435058
Autor:
Marta Gallach, Mercedes Vergara, Joao Pedro da Costa, Mireia Miquel, Meritxell Casas, Jordi Sanchez-Delgado, Blai Dalmau, Núria Rudi, Isabel Parra, Teresa Monllor, Meritxell Sanchez-Lloansí, Angelina Dosal, Oliver Valero, Xavier Calvet
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0208112 (2018)
BACKGROUND AND AIM:Treatment of hepatitis C with direct-acting antiviral agents (DAA) has few side effects. Although pivotal studies suggested that DAA were safe in patients with psychiatric diseases who could not be treated with previous antiviral t
Externí odkaz:
https://doaj.org/article/91db3feabd944fe8b221f4d7fdf932bc
Autor:
Juan José Urquijo, Moisés Diago, M.D., Jaume Boadas, Ramón Planas, Ricard Solá, Juan Angel del Olmo, Javier Crespo, José Carlos Erdozaín, María Dolores Antón, Carlos Arocena, Dolores Suarez, Josep Giné, Josep M Barrera, Javier Gracia-Samaniego, Ricardo Perez, Blai Dalmau, Miguel Montoro
Publikováno v:
Annals of Hepatology, Vol 12, Iss 1, Pp 30-35 (2013)
The hepatitis C virus (HCV) genotype is an important predictive outcome parameter for pegylated interferon plus ribavirin therapy. Most published therapeutic trials to date have enrolled mainly patients with HCV genotypes 1, 2 and 3. Limited studies
Externí odkaz:
https://doaj.org/article/98dcbc9f1b3644c49714f9f6fc02e4a9
Autor:
Mireia Miquel, Julia Sopeña, Mercedes Vergara, Montserrat Gil, Meritxell Casas, Jorge Sánchez-Delgado, Jordi Puig, Anna Alguersuari, Eva Criado, Blai Dalmau
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 104, Iss 5, Pp 242-247 (2012)
Background: hepatocellular carcinoma (HCC) is a very frequent tumor. Screening for the disease is effective, but the prognostic factors are difficult to evaluate. Objectives: 1. To determine epidemiological data and the clinical course of HCC in our
Externí odkaz:
https://doaj.org/article/a3023994448042588a22143da1bb8144
Autor:
Mercedes Vergara, Oliver Valero, Jordi Sánchez-Delgado, Leticia Hernandez, Eduard Brunet, Mireia Miquel, Meritxell Casas, Blai Dalmau
Publikováno v:
Medicina Clínica (English Edition). 152:377-383
Background and objectives Primary biliary cholangitis (PBC) is an autoimmune disease that affects the small bile ducts. The only treatments currently approved in our country are ursodeoxycholic acid (UDCA) and obeticholic acid. Different indices eval
Autor:
Oliver Valero, Blai Dalmau, Mercedes Vergara, Leticia Hernandez, Mireia Miquel, Eduard Brunet, Jordi Sánchez-Delgado, Meritxell Casas
Publikováno v:
Medicina Clínica. 152:377-383
Resumen Antecedentes y objetivos La colangitis biliar primaria (CBP) es una enfermedad autoinmunitaria que afecta a los conductos biliares de pequeno y mediano tamano. Los unicos tratamientos aprobados actualmente en nuestro pais son el acido ursodeo
Autor:
Enric Brullet, Meritxell Casas, Jordi Sánchez-Delgado, Xavier Calvet, Maria Rosa Bella, Mireia Miquel, Blai Dalmau, Félix Junquera, Rafael Campo, Eva Martínez-Bauer, Mercedes Vergara
Publikováno v:
Gastroenterología y Hepatología. 42:150-156
Resumen Introduccion En la endoscopia digestiva alta de pacientes con cirrosis hepatica a menudo se observan lesiones inespecificas, que se suelen orientar como gastropatia por hipertension portal (GHP). Sin embargo, el diagnostico de GHP puede ser d
Autor:
Félix Junquera, Jordi Sánchez-Delgado, Maria Rosa Bella, Mercedes Vergara, Enric Brullet, Rafael Campo, Blai Dalmau, Eva Martínez-Bauer, Xavier Calvet, Meritxell Casas, Mireia Miquel
Publikováno v:
Gastroenterología y Hepatología (English Edition). 42:150-156
Introduction Upper gastroscopy in patients with cirrhosis often reveals non-specific lesions, which are usually oriented as portal hypertensive gastropathy (PHG). However, the diagnosis of PHG can be difficult, both from an endoscopic and histologica